We are thrilled to announce the approval of Zendia GmbH’s USA Patent WO2018002327 titled “Rapid Test for Detecting Pathogens and…

Read more

Zendia GmbH is aiming to enter the market bolstered by a substantial grant of 290,000 Euros from the German Federal…

Read more

Together with Dr Gerald Tumussime and his team in Uganda, Zendia GmbH goes back to the district of Kyenjojo to get clinical data on the real world sensitivity of InfectoTest® on a particular population

Read more

Zendia GmbH received its first batch of lyophilized reagent beads from EVIK Diagnostics, Kanata, Canada. This acquisition marks the start…

Read more

InfectoTest® collaboration team received a positive answer from the ethics committee from Berlin and Frankfurt for the study protocol “Entwicklung…

Read more

Zendia GmbH proudly launched its first field feasibility study, a collaboration with the medical faculty at Ugandan Christian University Under the expert guidance of Dr Gerald Tumussime and his dedicated team in Kampala, this study marks a significant milestone for InfectoTest®

Read more

Zendia GmbH received feedback from the ethical committee from the Landesärztekammer Baden Württemberg regarding the submission of the Study Protocol…

Read more

We’re delighted to share that the commitment to innovative health solutions by the German Federal Ministry of Education and Research…

Read more

Today we published our work on the interactions of the Plasmodium falciparum parasite when confronted with hemolytic agents. This was…

Read more

InfectoTest® team with Zendia GmbH as a project leader, are honoured to be the recipients of a generous €1.1 million…

Read more

10/10